Identification and characterization of novel p14ARF  tumour suppressor binding partners.
Published: 2005
Language: eng
Number of pages: 196
Description: The ARF tumour suppressor is commonly deleted or mutated in a variety of cancers. ARF expression is induced in cells exposed to activated oncogenes and ionizing radiation suggesting a role for ARF in the cellular response to stress. The main function of ARF is to bind to HDM2 (MDM2 in mice) and to inhibit its E3 ubiquitin ligase activity towards p53 resulting in stabilization of p53 and commensurate cell cycle arrest. We performed a yeast two-hybrid analysis using full length human ARF as bait and identified two clones of particular interest that corresponded to sequences encoding the death domain-associated transcription co-repressor, DAXX, and the rDNA transcription terminating factor, TTF-1. We demonstrate that DAXX and TTF-1 bind to ARF both in vitro and in vivo and that ARF co-localizes with DAXX and TTF-1 at nuclear bodies and at nucleoli.The interaction between ARF and DAXX results in post-translational modifications of HDM2 which affect p53 stability and activity. ARF expression also influences the post-translational modification of DAXX itself. Furthermore, we observed that p53-stabilizing forms of cell stress, such as proteasome inhibition and heat shock, induce nucleolar accumulation of DAXX and enhanced co-localization with ARF possibly to assist in the regulation of p53 activity. Co-expression of ARF and TTF-1 results in nucleolar expression of p53 which is abrogated following RNA polymerase I inhibition. The interaction between ARF and TTF-1 does not inhibit TTF-1 binding to rDNA promoter elements and ARF is capable of co-complexing with TTF-1 at these sites suggesting a role for ARF in rDNA transcription events.In summary, we demonstrate for the first time that DAXX and TTF-1 are binding partners of the ARF tumour suppressor and that interactions between ARF and DAXX or TTF-1 can mediate p53 activity via effects on p53 transactivation, HDM2 stability and/or subcellular localization. These observations provide insight as to the functional significance of ARF during periods of cellular stress when ARF expression is upregulated and p53 is activated. The identification of ARF binding partners and their contribution to p53 function may implicate DAXX and TTF-1 as novel targets for future cancer therapies.
Notes: Thesis (Ph.D.)--University of Toronto, 2005.

Electronic version licensed for access by U. of T. users.

Source: Dissertation Abstracts International, Volume: 66-06, Section: B, page: 2959.